STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Medical Devices

NeuroNOS Earns FDA Orphan Drug Designation for Glioblastoma Therapy

byLiliana Vida
September 8, 2025
in Medical Devices, Mid-Cap, Pharmaceuticals
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

BA-101 aims to address urgent unmet needs in one of the deadliest brain cancers

NeuroNOS, a subsidiary of Beyond Air (XAIR), has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead investigational therapy, BA-101, for the treatment of glioblastoma (GBM). The designation provides significant incentives for development and represents an important step forward in addressing one of the most aggressive brain tumors in adults.

Glioblastoma remains one of the most difficult cancers to treat. Despite surgery, radiation, and chemotherapy with temozolomide being standard-of-care, these options are not curative. The median survival rate for patients is less than 12 months, with two- and five-year survival rates below 20% and 10%, respectively. This grim prognosis underscores the urgent need for novel treatment strategies.

“We are pleased to receive orphan drug designation from the FDA for the treatment of glioblastoma,” said Amir Avniel, CEO of NeuroNOS. “This marks our second orphan designation and highlights our mission to deliver targeted therapies for rare neurological conditions while advancing into oncology. We believe nitric oxide inhibition has the potential to transform patient outcomes.”

Research has increasingly shown that nitric oxide (NO) plays a role in modulating therapeutic responses in glioblastoma. By developing small molecule therapies that balance NO levels in the brain, NeuroNOS aims to pioneer a novel approach.

The FDA’s orphan designation is granted to drugs intended to treat rare diseases affecting fewer than 200,000 people in the U.S. Benefits include tax credits for clinical trials, waiver of certain fees, and seven years of market exclusivity if approved.

“Glioblastoma represents a profound unmet need,” added Prof. Haitham Amal, CSO of NeuroNOS. “We are committed to working with regulators, investigators, and patient groups to bring BA-101 into first-in-human studies as quickly as possible.”

You might like this article:Broadcom Delivers Stellar Quarter as AI Growth Accelerates

Tags: BreakingMoversNewsStock MarketXAIR
Previous Post

Broadcom Delivers Stellar Quarter as AI Growth Accelerates

Next Post

Eco Wave Power Launches First U.S. Wave Energy Project

Related Posts

Rivian Electric Pickup Truck

Rivian Cuts Delivery Forecast Amid Loss of EV Tax Credits

byLuca Blaumann
October 2, 2025
0

Shares fall as tariffs and policy shifts cloud the electric vehicle outlook Rivian Automotive (RIVN) trimmed the midpoint of its...

KULR Launches Next-Generation Battery Management System for Space and Defense

byLuca Blaumann
October 2, 2025
0

kBMS introduces radiation-tolerant design, redundancy, and enhanced efficiency for mission-critical applications KULR Technology Group (KULR), a Bitcoin+ Treasury company with...

drugs-4

Kenvue Rebounds After Tylenol Autism Claims Spark Market Jitters

byLuca Blaumann
September 23, 2025
0

Analysts cite lack of new scientific evidence as shares recover from record low Kenvue (KVUE) shares rose 6% on Tuesday,...

Next Post

Eco Wave Power Launches First U.S. Wave Energy Project

Latest News

Verizon Partners with AST SpaceMobile to Deliver Space-Based Cellular Coverage

Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant

Tech Rally Lifts S&P 500 and Nasdaq as AMD Soars on OpenAI Deal

AMD Soars 25% After Landmark AI Chip Deal With OpenAI

Dragonfly Energy Secures Nevada Tech Hub Funding to Strengthen Lithium Battery Innovation

Based on Your Interest

Rivian Electric Pickup Truck
Auto Manufacturers

Rivian Cuts Delivery Forecast Amid Loss of EV Tax Credits

October 2, 2025
Electrical Equipment

KULR Launches Next-Generation Battery Management System for Space and Defense

October 2, 2025
investing
Auto Manufacturers

Chijet Secures Up to $1 Billion in Expanded Private Placement

October 1, 2025

Recommended

Large-Cap

Nike Surprises Wall Street With Strong Q1 Results

September 30, 2025
Entertainment

Fubo Shareholders Approve Disney Merger With Hulu Live TV

September 30, 2025
Brokerages

Robinhood Surges on Prediction Market Growth

September 30, 2025
Large-Cap

Nike Faces Steep Profit Decline as Q1 Results Loom

September 29, 2025
Biotechnology

Drugmakers Gain as Markets Digest Trump’s Proposed 100% Pharma Tariffs

September 26, 2025
Stoxpo

Follow us on social media:

Highlights

  • Verizon Partners with AST SpaceMobile to Deliver Space-Based Cellular Coverage
  • Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant
  • Tech Rally Lifts S&P 500 and Nasdaq as AMD Soars on OpenAI Deal
  • AMD Soars 25% After Landmark AI Chip Deal With OpenAI
  • Dragonfly Energy Secures Nevada Tech Hub Funding to Strengthen Lithium Battery Innovation

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Verizon Partners with AST SpaceMobile to Deliver Space-Based Cellular Coverage

October 8, 2025
chemistry-2

Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant

October 7, 2025
investing

Tech Rally Lifts S&P 500 and Nasdaq as AMD Soars on OpenAI Deal

October 6, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.